3,097
Views
39
CrossRef citations to date
0
Altmetric
Review

Hepatitis E virus: Current epidemiology and vaccine

, , , &
Pages 2603-2610 | Received 08 Feb 2016, Accepted 27 Apr 2016, Published online: 24 Jul 2016

References

  • Buisson Y, Grandadam M, Nicand E, Cheval P, van Cuyck-Gandre H, Innis B, Rehel P, Coursaget P, Teyssou R, Tsarev S. Identification of a novel hepatitis E virus in Nigeria. J Gen Virol 2000; 81:903-9; PMID:10725415; http://dx.doi.org/10.1099/0022-1317-81-4-903
  • Ahmad I, Holla RP, Jameel S. Molecular virology of hepatitis E virus. Virus Res 2011; 161:47-58; PMID:21345356; http://dx.doi.org/10.1016/j.virusres.2011.02.011
  • Kmush B, Wierzba T, Krain L, Nelson K, Labrique AB. Epidemiology of hepatitis E in low- and middle-income countries of Asia and Africa. Semin Liver Dis 2013; 33:15-29; PMID:23564386; http://dx.doi.org/10.1055/s-0033-1338111
  • Zhuang H, Cao XY, Liu CB, Wang GM. Epidemiology of hepatitis E in China. Gastroenterologia Japonica 1991; 26 Suppl 3:135-8; PMID:1909252
  • Jia Z, Yi Y, Liu J, Cao J, Zhang Y, Tian R, Yu T, Wang H, Wang X, Su Q, et al. Epidemiology of hepatitis E virus in China: results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006. PloS One 2014; 9:e110837; PMID:25360522; http://dx.doi.org/10.1371/journal.pone.0110837
  • Khuroo MS, Rustgi VK, Dawson GJ, Mushahwar IK, Yattoo GN, Kamili S, Khan BA. Spectrum of hepatitis E virus infection in India. J Med Virol 1994; 43:281-6; PMID:7931190; http://dx.doi.org/10.1002/jmv.1890430316
  • Sridhar S, Lau SK, Woo PC. Hepatitis E: A disease of reemerging importance. J Formosan Med Assoc = Taiwan yi zhi 2015; 114:681-90; PMID:25773541; http://dx.doi.org/10.1016/j.jfma.2015.02.003
  • Aggarwal RGS. The global prevalence of hepatitis E virus infection and susceptibility: a systematic review Geneva, Switz, World Health Organization 2010
  • Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012; 55:988-97; PMID:22121109; http://dx.doi.org/10.1002/hep.25505
  • Lanini S, Garbuglia AR, Lapa D, Puro V, Navarra A, Pergola C, Ippolito G, Capobianchi MR. Epidemiology of HEV in the Mediterranean basin: 10-year prevalence in Italy. BMJ Open 2015; 5:e007110; PMID:26173715; http://dx.doi.org/10.1136/bmjopen-2014-007110
  • Guthmann JP, Klovstad H, Boccia D, Hamid N, Pinoges L, Nizou JY, Tatay M, Diaz F, Moren A, Grais RF, et al. A large outbreak of hepatitis E among a displaced population in Darfur, Sudan, 2004: the role of water treatment methods. Clin Infect Dis: Off Pub Infect Dis Soc Am2006; 42:1685-91; PMID:16705572; http://dx.doi.org/10.1086/504321
  • Investigation of hepatitis E outbreak among refugees - Upper Nile, South Sudan, 2012–2013. MMWR Morbid Mortal Weekly Rep 2013; 62:581-6; PMID:23884344
  • Ahmed JA, Moturi E, Spiegel P, Schilperoord M, Burton W, Kassim NH, Mohamed A, Ochieng M, Nderitu L, Navarro-Colorado C, et al. Hepatitis E outbreak, Dadaab refugee camp, Kenya, 2012. Emerg Infect Dis 2013; 19:1010-2; PMID:23735820; http://dx.doi.org/10.3201/eid1906.130275
  • Browne LB, Menkir Z, Kahi V, Maina G, Asnakew S, Tubman M, Elyas HZ, Nigatu A, Dak D, Maung UA, et al. Notes from the field: hepatitis E outbreak among refugees from South Sudan - Gambella, Ethiopia, April 2014-January 2015. MMWR Morbidity Mortality Weekly Rep 2015; 64:537; PMID:25996097
  • Centers for Disease C, Prevention. Investigation of hepatitis E outbreak among refugees - Upper Nile, South Sudan, 2012–2013. MMWR Morbidity Mortality Weekly Report 2013; 62:581-6; PMID:23884344
  • Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006; 16:5-36; PMID:16175650; http://dx.doi.org/10.1002/rmv.482
  • Perez-Gracia MT, Suay B, Mateos-Lindemann ML. Hepatitis E: an emerging disease. Infect, Genet Evolution: J Mol EpidemiolEvolutionary Genet Infect Dis 2014; 22:40-59; PMID:24434240; http://dx.doi.org/10.1016/j.meegid.2014.01.002
  • Zhang J, Shih JW, Wu T, Li SW, Xia NS. Development of the hepatitis E vaccine: from bench to field. Semin Liver Dis 2013; 33:79-88; PMID:23564392; http://dx.doi.org/10.1055/s-0033-1338116
  • Bradley DW. Hepatitis E virus: a brief review of the biology, molecular virology, and immunology of a novel virus. J Hepatol 1995; 22:140-5; PMID:7602068
  • Shrestha MP, Scott RM, Joshi DM, Mammen MP Jr, Thapa GB, Thapa N, Myint KS, Fourneau M, Kuschner RA, Shrestha SK, et al. Safety and efficacy of a recombinant hepatitis E vaccine. New Engl J Med 2007; 356:895-903; PMID:17329696; http://dx.doi.org/10.1056/NEJMoa061847
  • Haffar S, Bazerbachi F, Lake JR. Making the case for the development of a vaccination against hepatitis E virus. Liver Int: Off J Int Assoc Study Liver 2015; 35:311-6; PMID:24836400; http://dx.doi.org/10.1111/liv.12590
  • Khuroo MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 1980; 68:818-24; PMID:6770682; http://dx.doi.org/10.1016/0002-9343(80)90200-4
  • Gupta DN, Smetana HF. The histopathology of viral hepatitis as seen in the Delhi epidemic (1955–56). Indian J Med Res 1957; 45:101-13; PMID:13438544
  • Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP, Poleschuk VF. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983; 20:23-31; PMID:6409836; http://dx.doi.org/10.1159/000149370
  • Wong DC, Purcell RH, Sreenivasan MA, Prasad SR, Pavri KM. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet 1980; 2:876-9; PMID:6107544; http://dx.doi.org/10.1016/S0140-6736(80)92045-0
  • Khuroo MS. Chronic liver disease after non-A, non-B hepatitis. Lancet 1980; 2:860-1; PMID:6107528
  • Velazquez O, Stetler HC, Avila C, Ornelas G, Alvarez C, Hadler SC, Bradley DW, Sepulveda J. Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986–1987. Jama 1990; 263:3281-5; PMID:2112204; http://dx.doi.org/10.1001/jama.1990.03440240071018
  • Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organization 1992; 70:597-604; PMID:1464145
  • Corwin AL, Khiem HB, Clayson ET, Pham KS, Vo TT, Vu TY, Cao TT, Vaughn D, Merven J, Richie TL, et al. A waterborne outbreak of hepatitis E virus transmission in southwestern Vietnam. Am J Trop Med Hygiene 1996; 54:559-62; PMID:8686771
  • Utsumi T, Hayashi Y, Lusida MI, Amin M, Soetjipto, Hendra A, Soetjiningsih, Yano Y, Hotta H. Prevalence of hepatitis E virus among swine and humans in two different ethnic communities in Indonesia. Arch Virol 2011; 156:689-93; PMID:21191625; http://dx.doi.org/10.1007/s00705-010-0883-x
  • Kim JH, Nelson KE, Panzner U, Kasture Y, Labrique AB, Wierzba TF. A systematic review of the epidemiology of hepatitis E virus in Africa. BMC Infect Dis 2014; 14:308; PMID:24902967; http://dx.doi.org/10.1186/1471-2334-14-308
  • Khuroo MS. Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res 2011; 161:3-14; PMID:21320558; http://dx.doi.org/10.1016/j.virusres.2011.02.007
  • Purcell RH, Emerson SU. Hidden danger: the raw facts about hepatitis E virus. J Infect Dis 2010; 202:819-21; PMID:20695795; http://dx.doi.org/10.1086/655900
  • Ramachandran J, Eapen CE, Kang G, Abraham P, Hubert DD, Kurian G, Hephzibah J, Mukhopadhya A, Chandy GM. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol 2004; 19:134-8; PMID:14731121; http://dx.doi.org/10.1111/j.1440-1746.2004.03188.x
  • Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, Kennedy IT, Kitchen A, Patel P, Poh J, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014; 384:1766-73; PMID:25078306; http://dx.doi.org/10.1016/S0140-6736(14)61034-5
  • Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepatitis 2003; 10:61-9; PMID:12558914; http://dx.doi.org/10.1046/j.1365-2893.2003.00398.x
  • Khuroo MS. Hepatitis E: the enterically transmitted non-A, non-B hepatitis. Indian J Gastroenterol: Off J Indian Soc Gastroenterol 1991; 10:96-100; PMID:1916971
  • Chakraborty S, Datta M, Pasha ST, Kumar S. Non-A non-B viral hepatitis: a common-source outbreak traced to sewage contamination of drinking water. J Commun Dis 1982; 14:41-6; PMID:6815259
  • Teshale EH, Howard CM, Grytdal SP, Handzel TR, Barry V, Kamili S, Drobeniuc J, Okware S, Downing R, Tappero JW, et al. Hepatitis E epidemic, Uganda. Emerg Infect Dis 2010; 16:126-9; PMID:20031058; http://dx.doi.org/10.3201/eid1601.090764
  • Kerry Thomson JLDJLRL. Investigation of Hepatitis E Outbreak Among Refugees — Upper Nile, South Sudan, 2012–2013. Morbidity and Mortality Weekly Report (MMWR), CDC 2013; 62:581-6
  • H. LBBZMVKGMSAMTHZEANDDUAMJ. Notes from the Field: Hepatitis E Outbreak Among Refugees from South Sudan — Gambella, Ethiopia, April 2014–January 2015. Morbidity and Mortality Weekly Report (MMWR), CDC 2015; 64:537
  • XU Ke WA-p, ZHANG Jun, TIAN Hua, YAN Qiang, WU Zhi-ming, ZHANG Jun, ZHANG Xue-feng, TANG Fen-yang. Outbreak of hepatitis E among aged people in a nursing home. Chinese J Zoonoses 2012; 28:115-9
  • Aggarwal R. The Global Prevalence of Hepatitis E Virus Infection and Susceptibility: A Systematic Review. In: The Department of Immunization VaB ed.: World Health Organization, 2010
  • Guillois Y, Abravanel F, Miura T, Pavio N, Vaillant V, Lhomme S, Le Guyader FS, Rose N, Le Saux JC, King LA, et al. High Proportion of Asymptomatic Infections in an Outbreak of Hepatitis E Associated With a Spit-Roasted Piglet, France, 2013. Clin Infect Dis: Off Pub Infect Dis Soc Am 2016; 62:351-7; PMID:26429341; http://dx.doi.org/10.1093/cid/civ862
  • Arankalle VA, Chadha MS, Tsarev SA, Emerson SU, Risbud AR, Banerjee K, Purcell RH. Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent. Proc Nat Acad Sci U S A 1994; 91:3428-32; PMID:8159764; http://dx.doi.org/10.1073/pnas.91.8.3428
  • Bashir K, Hussain N, Hasnain S, Elahi S. Seroprevalence of hepatitis E virus immunoglobulin G and M antibodies in adults: a hospital-based study. Indian J Med Microbiol 2009; 27:139-41; PMID:19384037; http://dx.doi.org/10.4103/0255-0857.49427
  • Gurley ES, Hossain MJ, Paul RC, Sazzad HM, Islam MS, Parveen S, Faruque LI, Husain M, Ara K, Jahan Y, et al. Outbreak of hepatitis E in urban bangladesh resulting in maternal and perinatal mortality. Clin Infect Dis: Off Pub Infect Dis Soc Am 2014; 59:658-65; PMID:24855146; http://dx.doi.org/10.1093/cid/ciu383
  • Sharma SP. Hepatitis E and cholera outbreak in Kathmandu. CMAJ 2006; 175:860; PMID:17030933; http://dx.doi.org/10.1503/cmaj.061166
  • Labrique AB, Zaman K, Hossain Z, Saha P, Yunus M, Hossain A, Ticehurst JR, Nelson KE. Epidemiology and risk factors of incident hepatitis E virus infections in rural Bangladesh. Am J Epidemiol2010; 172:952-61; PMID:20801864; http://dx.doi.org/10.1093/aje/kwq225
  • icddr b. Health and Science Bulletin. 2009; 7:14-20
  • Rayis DA, Jumaa AM, Gasim GI, Karsany MS, Adam I. An outbreak of hepatitis E and high maternal mortality at Port Sudan, Eastern Sudan. PathogensGlobal Health 2013; 107:66-8; PMID:23683332; http://dx.doi.org/10.1179/2047773213Y.0000000076
  • Boccia D, Guthmann JP, Klovstad H, Hamid N, Tatay M, Ciglenecki I, Nizou JY, Nicand E, Guerin PJ. High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis 2006; 42:1679-84; PMID:16705571; http://dx.doi.org/10.1086/504322
  • Escriba JM, Nakoune E, Recio C, Massamba PM, Matsika-Claquin MD, Goumba C, Rose AM, Nicand E, Garcia E, Leklegban C, et al. Hepatitis E, Central African Republic. Emerg Infect Dis 2008; 14:681-3; PMID:18394300; http://dx.doi.org/10.3201/eid1404.070833
  • He J, Binn LN, Tsarev SA, Hayes CG, Frean JA, Isaacson M, Innis BL. Molecular characterization of a hepatitis E virus isolate from Namibia. J Biomed Sci 2000; 7:334-8; PMID:10895057; http://dx.doi.org/10.1007/BF02253253
  • Nicand E, Armstrong GL, Enouf V, Guthmann JP, Guerin JP, Caron M, Nizou JY, Andraghetti R. Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad. J Med Virol 2005; 77:519-21; PMID:16254969; http://dx.doi.org/10.1002/jmv.20487
  • Delarocque-Astagneau E, Abravanel F, Moshen A, Le Fouler L, Gad RR, El-Daly M, Ibrahim EM, El-Aidy S, Lashin T, El-Hoseiny M, et al. Epidemiological and virological characteristics of symptomatic acute hepatitis E in Greater Cairo, Egypt. Clin Microbiol Infect 2012; 18:982-8; PMID:22264267; http://dx.doi.org/10.1111/j.1469-0691.2011.03727.x
  • Maila HT, Bowyer SM, Swanepoel R. Identification of a new strain of hepatitis E virus from an outbreak in Namibia in 1995. J Gen Virol 2004; 85:89-95
  • Epelboin L, Nicand E, Roussin C, Lernout T, Pettinelli ME, Tesse S, Ali R, Aubry P. A sporadic case of genotype 3f acute hepatitis E in Mayotte. Med et Maladies Infect 2011; 41:392-4; PMID:21493025; http://dx.doi.org/10.1016/j.medmal.2011.02.013
  • Kamel AH, Ali MA, El-Nady HG, Deraz A, Aho S, Pothier P, Belliot G. Presence of enteric hepatitis viruses in the sewage and population of Greater Cairo. Clin Microbiol Infect 2011; 17:1182-5; PMID:21375654; http://dx.doi.org/10.1111/j.1469-0691.2011.03461.x
  • Wang HY. [Investigation of an outbreak of HNANB[E] in Shufu County, Xinjiang]. Zhonghua liu xing bing xue za zhi=Zhonghua liuxingbingxue zazhi 1989; 10:270-3; PMID:2515002
  • Li J. Clinical analysis of 70 elderly patients with viral hepatitis E China. Modern Med 2013; 20:41-3
  • Wang JQ, Liu JH, Guan CP, Zheng XY. Epidemiological characteristics of viral hepatitis in Fuzhou in 2007–2011. China Prev Med 2013; 14:43-6
  • Li FR, Ding H, Yao J, Wang XL, Tang YF, Bao ZF, Wang ZF, Gan WQ, Mao HY, Fontaine RE, Zeng G. An Outbreak of HEV Among Aged People in a Nursing Home. Chinese J Vaccines Immun 2007; 13:473-6
  • Tang QR, Zhu DD. Epidemiology of hepatitis E in Ningbo, 1999 - 2008. Dis Surveillance 2010; 25:258-60
  • Yu WH. Molecular epidemiology of swine HEV in a village of Yunnan. Chinese J Zoonoses 2012; 28:274-7
  • Wang YP, Zhao WH, Li AM, Li B, Ding L. Epidemiology of Hepatitis E in Jiangdu city. Jiangsu Health Care 2011; 13:2–3
  • Zhu FC, Huang SJ, Wu T, Zhang XF, Wang ZZ, Ai X, Yan Q, Yang CL, Cai JP, Jiang HM, et al. Epidemiology of zoonotic hepatitis E: a community-based surveillance study in a rural population in China. PloS One 2014; 9:e87154; PMID:24498033; http://dx.doi.org/10.1371/journal.pone.0087154
  • Okamoto H. Culture systems for hepatitis E virus. J Gastroenterol 2013; 48:147-58; PMID:23104469; http://dx.doi.org/10.1007/s00535-012-0682-0
  • Guu TS, Liu Z, Ye Q, Mata DA, Li K, Yin C, Zhang J, Tao YJ. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci U S A 2009; 106:12992-7
  • Purdy MA, McCaustland KA, Krawczynski K, Spelbring J, Reyes GR, Bradley DW. Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV). J M Virol 1993; 41:90-4; PMID:8228944; http://dx.doi.org/10.1002/jmv.1890410118
  • Zhang JZ, Ng MH, Xia NS, Lau SH, Che XY, Chau TN, Lai ST, Im SW. Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J Med Virol 2001; 64:125-32; PMID:11360244; http://dx.doi.org/10.1002/jmv.1027
  • Im SW, Zhang JZ, Zhuang H, Che XY, Zhu WF, Xu GM, Li K, Xia NS, Ng MH. A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus. Vaccine 2001; 19:3726-32; PMID:11395207; http://dx.doi.org/10.1016/S0264-410X(01)00100-1
  • Yarbough PO. Hepatitis E virus. Advances in HEV biology and HEV vaccine approaches. Intervirology 1999; 42:179-84; PMID:10516473; http://dx.doi.org/10.1159/000024978
  • Arankalle VA, Lole KS, Deshmukh TM, Srivastava S, Shaligram US. Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes. Vaccine 2009; 27:1032-9; PMID:19095027; http://dx.doi.org/10.1016/j.vaccine.2008.11.097
  • Li SW, Zhang J, Li YM, Ou SH, Huang GY, He ZQ, Ge SX, Xian YL, Pang SQ, Ng MH, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005; 23:2893-901; PMID:15780738; http://dx.doi.org/10.1016/j.vaccine.2004.11.064
  • Purcell RH, Nguyen H, Shapiro M, Engle RE, Govindarajan S, Blackwelder WC, Wong DC, Prieels JP, Emerson SU. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 2003; 21:2607-15; PMID:12744897; http://dx.doi.org/10.1016/S0264-410X(03)00100-2
  • Huang WJ, Zhang HY, Harrison TJ, Lan HY, Huang GY, Wang YC. Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4. Archives Virol 2009; 154:481-8; PMID:19240977; http://dx.doi.org/10.1007/s00705-009-0335-7
  • Zhang M, Emerson SU, Nguyen H, Engle R, Govindarajan S, Blackwelder WC, Gerin J, Purcell RH. Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques. Vaccine 2002; 20:3285-91; PMID:12213398; http://dx.doi.org/10.1016/S0264-410X(02)00314-6
  • Kamili S, Spelbring J, Carson D, Krawczynski K. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection. J Infect Dis 2004; 189:258-64; PMID:14722891; http://dx.doi.org/10.1086/380801
  • Yang C, Pan H, Wei M, Zhang X, Wang N, Gu Y, Du H, Zhang J, Li S, Xia N. Hepatitis E virus capsid protein assembles in 4 M urea in the presence of salts. Protein Sci: Pub Protein Soc 2013; 22:314-26; PMID:23281113; http://dx.doi.org/10.1002/pro.2213
  • Li SW, Zhang J, He ZQ, Gu Y, Liu RS, Lin J, Chen YX, Ng MH, Xia NS. Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. J Biol Chem 2005; 280:3400-6; PMID:15557331; http://dx.doi.org/10.1074/jbc.M410361200
  • Li S, Tang X, Seetharaman J, Yang C, Gu Y, Zhang J, Du H, Shih JW, Hew CL, Sivaraman J, et al. Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction. PLoS Pathogens 2009; 5:e1000537; PMID:19662165; http://dx.doi.org/10.1371/journal.ppat.1000537
  • Li F, Torresi J, Locarnini SA, Zhuang H, Zhu W, Guo X, Anderson DA. Amino-terminal epitopes are exposed when full-length open reading frame 2 of hepatitis E virus is expressed in Escherichia coli, but carboxy-terminal epitopes are masked. J Med Virol 1997; 52:289-300; PMID:9210039; http://dx.doi.org/10.1002/(SICI)1096-9071(199707)52:3%3c289::AID-JMV10%3e3.0.CO;2-E
  • Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376:895-902; PMID:20728932; http://dx.doi.org/10.1016/S0140-6736(10)61030-6
  • Zhao Q, Zhang J, Wu T, Li SW, Ng MH, Xia NS, Shih JW. Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy. J Gastroenterol 2013; 48:159-68; PMID:23149436; http://dx.doi.org/10.1007/s00535-012-0701-1
  • Zhang J, Zhang XF, Huang SJ, Wu T, Hu YM, Wang ZZ, Wang H, Jiang HM, Wang YJ, Yan Q, et al. Long-term efficacy of a hepatitis E vaccine. New Eng J Med 2015; 372:914-22; PMID:25738667; http://dx.doi.org/10.1056/NEJMoa1406011
  • Wang X, Li M, Li S, Wu T, Zhang J, Xia N, Zhao Q. Prophylaxis against hepatitis E: at risk populations and human vaccines. Exp Rev Vacc 2016:1-13; PMID:26775537; http://dx.doi.org/10.1586/14760584.2016.1143365
  • Zhang X, Wei M, Pan H, Lin Z, Wang K, Weng Z, Zhu Y, Xin L, Zhang J, Li S, et al. Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin®. Vaccine 2014; 32:4039-50; PMID:24892250; http://dx.doi.org/10.1016/j.vaccine.2014.05.064
  • Reports on Notifiable Infectious Disease in China. Chinese Center for Disease Control and Prevention. Available online at: http://www.chinacdc.cn/tjsj/fdcrbbg/
  • Joshi RM. Hepatitis E virus: a renewed hope with Hecolin. Clin Microbiol 2014; 4; PMID:25110719
  • Labrique AB, Sikder SS, Krain LJ, West KP Jr, Christian P, Rashid M, Nelson KE. Hepatitis E, a vaccine-preventable cause of maternal deaths. Emerg Infect Dis 2012; 18:1401-4; PMID:22931753; http://dx.doi.org/10.3201/eid1809.120241
  • Park SB. Hepatitis E vaccine debuts. Nature 2012; 491:21-2; PMID:23128204; http://dx.doi.org/10.1038/491021a
  • Zhang J, Liu CB, Li RC, Li YM, Zheng YJ, Li YP, Luo D, Pan BB, Nong Y, Ge SX, et al. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine 2009; 27:1869-74; PMID:19168109; http://dx.doi.org/10.1016/j.vaccine.2008.12.061
  • Lam E, McCarthy A, Brennan M. Vaccine-preventable diseases in humanitarian emergencies among refugee and internally-displaced populations. Hum Vacc Immunotherap 2015; 11:2627-36; PMID:26406333; http://dx.doi.org/10.1080/21645515.2015.1096457
  • Ferguson M, Walker D, Mast E, Fields H. Report of a collaborative study to assess the suitability of a reference reagent for antibodies to hepatitis E virus. Biolog: J Int Assoc Biolog Standardization 2002; 30:43-8; PMID:11846429; http://dx.doi.org/10.1006/biol.2001.0315
  • WHO Technical report. Waterborne Outbreaks of Hepatitis E: recognition, investigation and control. 2014. Available online at: http://www.who.int/hiv/pub/hepatitis/HepE-manual/en/
  • WHO. Recommendations of HEV Working Group on the use of hepatitis E vaccine. 2014. Available online at: http://www.who.int/immunization/sage/meetings/2014/october/3_Hep_E_vacc_WG_SAGE_Recs_final_1Oct2014.pdf
  • Who. Hepatitis E vaccine: WHO position paper, May 2015 - Recommendations. Vaccine 2016; 34:304-5; PMID:26232546; http://dx.doi.org/10.1016/j.vaccine.2015.07.056
  • Gu Y, Tang X, Zhang X, Song C, Zheng M, Wang K, Zhang J, Ng MH, Hew CL, Li S, et al. Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody. Cell Res 2015; 25:604-20; PMID:25793314; http://dx.doi.org/10.1038/cr.2015.34
  • Zhao Q, Li S, Yu H, Xia N, Modis Y. Virus-like particle-based human vaccines: quality assessment based on structural and functional properties. Trends Biotechnol 2013; 31:654-63; PMID:24125746; http://dx.doi.org/10.1016/j.tibtech.2013.09.002
  • Zhang X, Xin L, Li S, Fang M, Zhang J, Xia N, Zhao Q. Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins. Hum Vacc Immunotherap 2015; 11:1277-92; PMID:25751641; http://dx.doi.org/10.1080/21645515.2015.1016675
  • Xu M, Liang Z, Xu Y, Wang J. Chinese vaccine products go global: vaccine development and quality control. Exp Rev Vacc 2015; 14:763-73; PMID:25697690; http://dx.doi.org/10.1586/14760584.2015.1012503

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.